BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 3230641)

  • 1. [Refractory anemia showing excess of blasts (BAEB) that transformed into acute myelogenous leukemia (AML-M2) with a t (?8;20) chromosomal abnormality].
    Maekawa T; Fujii H; Shizumi Y; Ebisui S; Horishi M; Suyama Y; Miyoshi M; Horiike S
    Gan No Rinsho; 1988 Dec; 34(15):2109-13. PubMed ID: 3230641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acquisition of Philadelphia chromosome with bcr rearrangement concomitant with transformation of refractory anemia with excess of blasts with 8 trisomy into acute myelogenous leukemia].
    Niikura H; Fujita K; Terada H; Haga A; Yamashina A
    Rinsho Ketsueki; 1990 Mar; 31(3):335-40. PubMed ID: 2366338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia.
    Estey EH; Keating MJ; Dixon DO; Trujillo JM; McCredie KB; Freireich EJ
    Hematol Pathol; 1987; 1(4):203-8. PubMed ID: 3504436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy-related leukemia with t(8;21) initially diagnosed as MDS (RAEB in T)].
    Hanamura A; Ichikawa A
    Rinsho Ketsueki; 1995 Aug; 36(8):755-61. PubMed ID: 7563609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High degree of myeloid differentiation and granulocytosis is associated with t(8;21) smoldering leukemia.
    Yamasaki H; Era T; Asou N; Sanada I; Matutes E; Yamaguchi K; Takatsuki K
    Leukemia; 1995 Jul; 9(7):1147-53. PubMed ID: 7630188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
    Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M
    Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An adolescent case of myelodysplastic syndrome following aplastic anemia].
    Yoshihara T; Morimoto A; Itoi T; Nakagawa M; Kawakatsu H; Todo S; Morioka Y; Imashuku S; Hayano T; Okamoto T
    Rinsho Ketsueki; 1989 Jan; 30(1):78-83. PubMed ID: 2716203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
    Ogasawara T; Yasuyama M; Kawauchi K
    Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Refractory anemia with excess of blasts (RAEB) with a high level of HbF that preceded apparent pancytopenia].
    Matsuda A; Kusumoto S; Ito K; Yokoo H; Maruyama T; Jinnai I; Harano T; Watanabe K; Hirashima K
    Rinsho Ketsueki; 1996 Jan; 37(1):60-4. PubMed ID: 8683869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal karyotype evolution involving ring chromosome 1 with myelodysplastic syndrome subtype RAEB-t progressing into acute leukemia.
    Duell T; Poleck-Dehlin B; Schmid C; Wunderlich B; Ledderose G; Mittermuller J; Kolb HJ; Schmetzer H
    Acta Haematol; 2006; 116(2):131-6. PubMed ID: 16914909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute promyelocytic leukemia with a history of RAEB in transformation and the 15/17 translocation].
    Ogawa K; Shineha H; Abe R; Shichishima T; Kimura H; Yui T; Kawaguchi M; Matsuda S; Uchida T; Kariyone S
    Rinsho Ketsueki; 1989 Jan; 30(1):67-71. PubMed ID: 2716201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the KIT gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia.
    Lorenzo F; Nishii K; Monma F; Kuwagata S; Usui E; Shiku H
    Leuk Res; 2006 Oct; 30(10):1235-9. PubMed ID: 16533529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Altered expression of protooncogenes during clinical course in an AML case transformed from MDS].
    Fujikawa T; Horiguchi J; Iizuka K; Nemoto T; Iwase S; Yamamura S; Inaba S; Yamazaki Y; Sano S; Yamada H
    Rinsho Ketsueki; 1991 Sep; 32(9):986-90. PubMed ID: 1942545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
    Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK
    Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
    Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
    Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal monosomy of chromosome 21 in a case of myelodysplastic syndrome.
    Freitas PC; Carvalho-Salles AB; Mendiburu CF; Ricci O; Fett-Conte AC
    Genet Mol Res; 2011 Nov; 10(4):2718-20. PubMed ID: 22095597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of monocytic leukaemia cutis in a patient with myelodysplastic syndrome transforming to acute myeloid leukaemia.
    Perez A; Kennedy C; Standen G; Oxley J
    Clin Exp Dermatol; 2004 Sep; 29(5):497-8. PubMed ID: 15347335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory anaemia with excess of blasts in transformation re-evaluated with the WHO criteria: identification of subgroups with different survival.
    Breccia M; Latagliata R; Carmosino I; Gentilini F; D'Elia GM; Levi A; Natalino F; Frustaci A; De Cuia MR; Alimena G
    Acta Haematol; 2007; 117(4):221-5. PubMed ID: 17259693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia.
    La Starza R; Trubia M; Testoni N; Ottaviani E; Belloni E; Crescenzi B; Martelli M; Flandrin G; Pelicci PG; Mecucci C
    Haematologica; 2002 Aug; 87(8):789-94. PubMed ID: 12161353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.